Child Neurology Society's Brainstorm cover image

CNS Brainstorm Episode 48 "Pediatric NF1 Therapeutics" with guest Bonnie Kaur, MD

Child Neurology Society's Brainstorm

00:00

Mirdametinib approval and outcomes

Bonnie Kaur details mirdametinib's 2025 approval, response rates, median tumor reduction, and similar side effects profile.

Play episode from 06:32
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app